Data / Drug companies / Apothecon Pharmaceuticals Pvt Ltd
Apothecon Pharmaceuticals Pvt Ltd: 39 products in the FDA NDC directory, labeler code 76339
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Apothecon Pharmaceuticals Pvt Ltd (labeler code 76339) lists 39 products in the FDA National Drug Code Directory. By type: 39 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 26, 2026.
The request: Watch Apothecon Pharmaceuticals Pvt Ltd (FDA labeler code 76339): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76339
- Products in commercial distribution
- 39
- Packages
- 106
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- September 6, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 39 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 39 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 37 | 94.9% |
| Liquid | 2 | 5.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Rilpivirine hydrochloride | 76339-507 | Powder | Bulk ingredients | October 26, 2026 |
| Glycerol phenylbutyrate | 76339-517 | Powder | Bulk ingredients | November 8, 2025 |
| Sodium phenylbutyrate | 76339-510 | Powder | Bulk ingredients | November 8, 2025 |
| Cisatracurium besylate | 76339-192 | Powder | Bulk ingredients | November 8, 2025 |
| Maraviroc | 76339-516 | Powder | Bulk ingredients | June 16, 2025 |
| Sevelamer carbonate | 76339-511 | Powder | Bulk ingredients | December 10, 2024 |
| Tafamidis meglumine | 76339-195 | Powder | Bulk ingredients | December 10, 2024 |
| Melphalan hydrochloride | 76339-501 | Powder | Bulk ingredients | January 31, 2024 |
| Salcaprozate sodium | 76339-505 | Powder | Bulk ingredients | November 28, 2023 |
| Diazepam | 76339-508 | Powder | Bulk ingredients | November 24, 2023 |
| Colesevelam hydrochlpride | 76339-500 | Powder | Bulk ingredients | November 24, 2023 |
| Sevelamer hydrochloride | 76339-196 | Powder | Bulk ingredients | November 24, 2023 |
| Hydralazine hydrochloride | 76339-197 | Powder | Bulk ingredients | November 23, 2023 |
| Sevelamer carbonate | 76339-167 | Powder | Bulk ingredients | November 23, 2023 |
| Iron sucrose complex | 76339-166 | Powder | Bulk ingredients | November 23, 2023 |
| Salcaprozate sodium | 76339-179 | Powder | Bulk ingredients | November 4, 2022 |
| Cyclophosphamide | 76339-191 | Powder | Bulk ingredients | September 23, 2022 |
| Ropivacaine hydrochloride | 76339-124 | Powder | Bulk ingredients | November 24, 2021 |
| Miglustat | 76339-178 | Powder | Bulk ingredients | October 26, 2021 |
| Sodium phenyl acetate | 76339-139 | Powder | Bulk ingredients | October 8, 2021 |
| Cyclophosphamide | 76339-164 | Powder | Bulk ingredients | August 24, 2021 |
| Nicardipine hydrochloride | 76339-117 | Powder | Bulk ingredients | December 5, 2020 |
| Colesevelam hydrochloride | 76339-153 | Powder | Bulk ingredients | July 14, 2020 |
| Ropivacaine | 76339-126 | Powder | Bulk ingredients | December 28, 2019 |
| Indomethacin sodium | 76339-301 | Powder | Bulk ingredients | October 3, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.